Comparison
Both do ambient documentation well. The practical differences are that SyntheNote publishes what it costs, has a standing free plan rather than a trial, shows you which sentences in a note are actually supported by the recording, and carries the rest of the visit in the same app.
“85,000+ clinicians”— Nabla's own positioning
Nabla is an established ambient scribe with a large clinician base and a serious engineering reputation, sold both to individuals and to organisations. Like most of the category above the self-serve tier, it does not publish pricing, so the first step is a conversation rather than a signup.
| SyntheNote | Nabla | |
|---|---|---|
| Price | Free, then $13.99–$199 a month, published | Not published |
| Free path | Free plan: 10 recordings and 25 notes a month, no card | Trial by arrangement |
| Grounding check | Each sentence traced to the transcript; unsupported ones flagged | Not published in these terms |
| Languages | 35, including a patient moving between two in one sentence | Multilingual |
| Offline | Records with no signal, holds it encrypted, sends itself on reconnect | Not a published feature |
| Beyond the note | Ask a patient record; scheduling, video visits, prescriptions, coding | Focused on documentation |
| Proof | New — no public clinician count yet | 85,000+ clinicians |
Nabla has 85,000 clinicians and SyntheNote has a free plan and an argument — the scale difference is real and worth weighing. Neither writes back into an EHR directly from what each publishes. If you want the tool most of your colleagues have already heard of, that is Nabla today.
The free plan covers 10 recordings a month and needs no card. That is enough to find out whether the note is one you would sign.